Pulmonary Transplantation Council Year in Review
David Weill, MD
Our Pulmonary Transplantation Council had another productive meeting at the ISHLT Conference in Montréal.
Some of the meeting highlights include the organization of a formal working group regarding Antibody Mediated Rejection (AMR), which will foster collaboration with other Councils while also adding the pulmonary perspective to this important clinical problem. There was also discussion of how to proceed with regards to Ex Vivo Lung Perfusion. There was broad agreement that we summarize what we know now and how to proceed going forward, particularly with regard to formation of a registry and policy recommendations addressing EVLP and lung allocation. There was recognition that it was too early to come to consensus about EVLP but that, as a Council, we should begin to express what is known at this point. This effort will be performed jointly with members of the American Society of Transplantation.
There was also discussion at the Council meeting and the ISHLT Board of Directors meeting subsequently about the Chronic Lung Allograft Dysfunction (CLAD) manuscript that was drafted by some of our Council meetings. It was decided that, in order for the document to be considered an official Pulmonary Council publication (although not an official "Guideline"), it would first need to be vetted by the entire Council. Toward that end, the document has been sent to Council members for public comment (due May 10th).
As a reminder, regarding the 2014 ISHLT meeting in San Diego, please remember to get in your Symposia ideas by June 21.
These were just some of the highlights. I will outline more 2013-2014 goals in a subsequent LINKS issue. Finally, it has been a privilege to be your Council Chair the last year, and I look forward to serving another year. I also want to thank our Vice-Chair Mike Mulligan and Past Chair Lianne Singer for their support of our activities. Please contact me with comments (constructive or otherwise) on how we as a Council can be more effective.
Disclosure Statement: The author has no conflicts of interest to disclose.